One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 170,000 shares of Pfizer Inc. (NYSE: PFE) on Thursday, as the price of this fund was down over 1% in the day’s session. It is still up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 173,579 shares of Pfizer. At Thursday’s closing price, this would have valued this purchase at roughly $8.2 million. This is only a small fraction of the total holdings. The fund is up 36% over the past 52 weeks.
Check out all the ARK Invest buys for Thursday:
Fund | Ticker | Name | Shares |
---|---|---|---|
ARKF | PDD | PINDUODUO | 59,300 |
ARKF | COIN | COINBASE GLOBAL | 7,054 |
ARKG | RPTX | REPARE THERAPEUTICS | 2,468 |
ARKG | QSI | QUANTUM-SI | 34,201 |
ARKG | PSNL | PERSONALIS | 40,468 |
ARKG | PFE | PFIZER | 173,579 |
ARKG | MASS | 908 DEVICES | 25,000 |
ARKG | DYNS | DYNAMICS SPECIAL PURPOSE | 1,696 |
ARKG | ADPT | ADAPTIVE BIOTECHNOLOGIES | 62,252 |
ARKG | BEAM | BEAM THERAPEUTICS | 17,033 |
ARKG | CMIIU | CM LIFE SCIENCES II | 25,000 |
ARKK | VCYT | VERACYTE | 26,653 |
ARKK | NVTA | INVITAE | 319,045 |
ARKK | SGFY | SIGNIFY HEALTH | 178,955 |
ARKK | FATE | FATE THERAPEUTICS | 60,075 |
ARKQ | KTOS | KRATOS DEFENSE & SECURITY SOLUTIONS | 201,508 |
ARKQ | KMTUY | KOMATSU | 21,700 |
ARKQ | AVAV | AEROVIRONMENT | 8,767 |
ARKQ | ACIC | ATLAS CREST INVESTMENT | 460,000 |
ARKW | SPLK | SPLUNK | 116,466 |
ARKW | LPSN | LIVEPERSON | 23,856 |
ARKW | GENI | GENIUS SPORTS | 135,457 |
ARKX | PRNT | 3D PRINTING ETF | 12,670 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.